Skip to main content
Log in

The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Said S.I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science 169: 1217, 1970.

    Article  PubMed  CAS  Google Scholar 

  2. Said S.I. VIP overview. In: Bloom S.R., Polak J.M. (Eds.), Gut hormones. Churchill Livingstone, Edinburgh, 1981, p. 379.

    Google Scholar 

  3. Said S.I., Giachetti A., Nicosia S. VIP: possible functions as a neural peptide. In: Costa E., Trabucchi M. (Eds.), Neural peptides and neuronal communication. Raven Press, New York, 1980, p. 75.

    Google Scholar 

  4. Nicosia S., Spada A., Giannattasio G. Effects of Vasoactive Intestinal Polypeptide on the pituitary gland. In: Said S.I. (Ed.), Vasoactive Intestinal Peptide. Raven Press, New York, 1982, p. 263.

    Google Scholar 

  5. Said S.I., Porter J.C. Vasoactive Intestinal Polypeptide: release into hypophyseal portal blood. Life Sci. 24: 227, 1979.

    Article  PubMed  CAS  Google Scholar 

  6. Shimatsu A., Kato Y., Matsushita N., Katakami H., Yanaihara N., Imura H. Immunoreactive Vasoactive Intestinal Polypeptide in rat hypophysial protal blood. Endocrinology 108: 395, 1981.

    Article  PubMed  CAS  Google Scholar 

  7. Said S.I., Rosenberg R.N. Vasoactive Intestinal Polypeptide; abundant immuno-reactivity in neural cell lines and normal nervous tissue. Science 192: 907, 1976.

    Article  PubMed  CAS  Google Scholar 

  8. Giachetti A., Said S.I., Reynolds R.C., Koniges F.C. Vasoactive Intestinal Polypeptide in brain: localization in and release from isolated nerve terminals. Proc. Natl. Acad. Sci. USA 74: 3424, 1977.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  9. Fahrenkrug J., Schaffalitzky de Muckadell O.B. Distribution of Vasoactive Intestinal Polypeptide (VIP) in the porcine central nervous system. J. Neurochem. 31: 1445, 1978.

    Article  PubMed  CAS  Google Scholar 

  10. Besson J., Rotsztejn W., Laburthe M., Epelbaum J., Beaudet A., Kordon C., Rosselin G. Vasoactive Intestinal Peptide (VIP): brain distribution, subcellular localization and effect of deafferentation of the hypothalamus in male rats. Brain Res. 165: 79, 1979.

    Article  PubMed  CAS  Google Scholar 

  11. Loren I., Emson P.C., Fahrenkrug J., Björklund A., Alumets J., Hakanson R., Sundler F. Distribution of Vasoactive Intestinal Polypeptide in the rat and mouse brain. Neuroscience 4: 1953, 1979.

    Article  PubMed  CAS  Google Scholar 

  12. Samson W.K., Said S.I., McCann S.M. Radioimmunologic localization of Vasoactive Intestinal Polypeptide in hypothalamic and extrahypothalamic sites in the rat brain. Neurosci. Lett. 12: 265, 1979.

    Article  PubMed  CAS  Google Scholar 

  13. Sims K.B., Hoffman D.L., Said S.I., Zimmerman E.A. Vasoactive Intestinal Polypeptide (VIP) in mouse and rat brain: an immunocytochemical study. Brain Res. 186: 165, 1980.

    Article  PubMed  CAS  Google Scholar 

  14. Samson W.K., Said S.I., Graham J.W., McCann S.M. Vasoactive Intestinal Polypeptide concentrations in median eminence of hypothalamus. Lancet II: 901, 1978.

    Article  Google Scholar 

  15. Emson P.C., Fahrenkrug J., Spokes E.G.S. Vasoactive Intestinal Polypeptide (VIP): distribution in normal human brain and in Huntington’s disease. Brain Res. 173: 174, 1979.

    Article  PubMed  CAS  Google Scholar 

  16. Vijayan E., Samson W.K., Said S.I., McCann S.M. Vasoactive Intestinal Peptide: evidence for a hypothalamic site of action to release growth hormone, luteinizing hormone, and prolactin in conscious ovariectomized rats. Endocrinology 104: 53, 1979.

    Article  PubMed  CAS  Google Scholar 

  17. Ruberg M., Rotsztejn W.K, Arancibia S., Besson J., Enjalbert A. Stimulation of prolactin release by Vasoactive Intestinal Peptide (VIP). Eur. J. Pharmacol. 51: 319, 1978.

    Article  PubMed  CAS  Google Scholar 

  18. Enjalbert A., Arancibia S., Ruberg M., Priam M., Bluet-Pajot M.T., Rotsztejn W.K., Kordon C. Stimulation of in vitro prolactin release by Vasoactive Intestinal Peptide. Neuroendocrinology 31: 200, 1980.

    Article  PubMed  CAS  Google Scholar 

  19. Rotsztejn W.K., Benoist L., Besson J., Beraud G., Bluet-Pajot M.T., Kordon C., Rosselin G., Duval J. Effect of Vasoactive Intestinal Peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Neuroendocrinology 31: 282, 1980.

    Article  PubMed  CAS  Google Scholar 

  20. Samson W.K., Koning J., Reeves J., McCann S.M. Vasoactive Intestinal Polypeptide stimulates LHRH release from hypothalamic synaptosomes. Proceedings of the 62nd Annual Meeting of the Endocrine Society, p. 261, 1980. (Abstract).

    Google Scholar 

  21. Epelbaum J., Tapia-Arancibia L., Besson J., Rotsztejn W.H., Kordon C. Vasoactive Intestinal Peptide inhibits release of somatostatin from hypothalamus in vitro. Eur. J. Pharmacol. 58: 493, 1979.

    Article  PubMed  CAS  Google Scholar 

  22. Enjalbert A., Epelbaum J., Arancibia S., Tapia-Arancibia L., Bleut-Pajot M., Kordon C. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro. Endocrinology 111: 42, 1982.

    Article  PubMed  CAS  Google Scholar 

  23. Matsushita N., Kato Y., Katakami H., Shimatsu A., Yanaihara N., Imura H. Stimulation of growth hormone release by vasoactive intestinal polypeptide from human pituitary adenomas in vitro. J. Clin. Endocrinol. Metab. 53:1297, 1981.

    Article  PubMed  CAS  Google Scholar 

  24. Chihara K., Iwasaki J., Minamitani N., Kaji H., Matsukura S., Tamaki N, Matsumoto S., Fujita T. Effect of Vasoactive Intestinal Polypeptide on growth hormone secretion in perifused acromegalic pituitary adenoma tissues. J. Clin. Endocrinol. Metab. 54: 773, 1982.

    Article  PubMed  CAS  Google Scholar 

  25. Faglia G., Beck-Peccoz P., Ferrari C., Travaglini P., Ambrosi B., Spada A. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly. J. Clin. Endocrinol. Metab. 36: 1259, 1973.

    Article  PubMed  CAS  Google Scholar 

  26. Rubin A.L., Levin S.R., Bernstein R.I., Tyrrell J.B., Noacco C., Forsham P.M. Stimulation of growth hormone by luteinizing hormone-releasing hormone in active acromegaly. J. Clin. Endocrinol. Metab. 37: 160, 1973.

    Article  PubMed  CAS  Google Scholar 

  27. Liuzzi A., Chiodini P.G., Botalla L., Cremascoli G., Silvestrini F. Inhibitory effect of L-dopa on GH release in acromegalic patients. J. Clin. Endocrinol. Metab. 35: 941, 1972.

    Article  PubMed  CAS  Google Scholar 

  28. Kato Y., Iwasaki Y., Iwasaki J., Abe H., Yanaihara N., Imura H. Prolactin release by Vasoactive Intestinal Polypeptide in rats. Endocrinology 103: 554, 1978.

    Article  PubMed  CAS  Google Scholar 

  29. Shaar C.J., Clemes J.A., Dininger N.B. Effect of Vasoactive Intestinal Polypeptide on prolactin release in vitro. Life Sci. 25: 2071, 1979.

    Article  PubMed  CAS  Google Scholar 

  30. Samson W.K., Said S.I., Snyder G., McCann S.M. In vitro stimulation of-prolactin release by Vasoactive Intestinal Peptide. Peptides 1: 325, 1980.

    Article  PubMed  CAS  Google Scholar 

  31. Gourdji D., Bataille D., Vauclin N., Grouselle D., Rosselin G., Tixier-Vidal A. Vasoactive Intestinal Peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release. FEBS Lett. 104: 165, 1979.

    Article  PubMed  CAS  Google Scholar 

  32. Fawley L.S., Neill J.D. Stimulation of prolactin secretion in rhesus monkeys by Vasoactive Intestinal Polypeptide. Neuroendocrinology 33: 79, 1981.

    Article  Google Scholar 

  33. Bataille D., Talbot J.N., Milhaud G., Mutt V., Rosselin G. Effect du peptide intestinal vasoactif (VIP) sur la secretion de prolactine chez I’homme. C.R. Acad. Sc. Paris 292: 511, 1981.

    CAS  Google Scholar 

  34. Ottesen B., Andersen A.N., Gerstenberg T., Ulrichsen H., Manthorpe T., Fahrenkrug J. VIP stimulates prolcatin release in women. Lancet II, 696, 1981.

    Article  Google Scholar 

  35. Malarkey W.B., O’Dorisio T.M., Kennedy M., Cataland S. The influence of Vasoactive Intestinal Polypeptide and chelocystokinin on prolactin release in rat and human monolayer cultures. Life Sci., 28: 2489, 1981.

    Article  PubMed  CAS  Google Scholar 

  36. Nicosia S., Spada A., Borghi C., Cortelazzi L., Giannattasio G. Effects of Vasoactive Intestinal Polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas. Stimulation of PRL release and activation of adenylate cyclase. FEBS Lett. 112: 159, 1980.

    Article  PubMed  CAS  Google Scholar 

  37. Spada A., Nicosia S., Cortelazzi L., Pezzo G., Bassetti M., Sartorio A., Giannattasio G. In vitro studies on prolactin release and adenylate cyclase activity in human prolactin-secreting pituitary adenomas. Different sensitivity of macro and microadenomas to dopamine and vasoactive intestinal poplypeptide. J. Clin. Endocrinol. Metab. 56: 1, 1983.

    Article  PubMed  CAS  Google Scholar 

  38. McLeod R.M. Regulation of prolactin secretion. In: Martini L., Ganong W.F. (Eds.), Frontiers in neuroendocrinology. Raven Press, New York, 1976, vol. 4, p. 169.

    Google Scholar 

  39. Drouin J., De Lean A., Rainville D., Lachance R., Labrie F. Characteristics of the interaction between thyrotropin releasing hormone and somatostatin for thyrotropin and prolactin release. Endocrinology 98: 514, 1976.

    Article  PubMed  CAS  Google Scholar 

  40. Rotsztejn W.H., Dussaillant M, Nobou F., Rosselin G. Rapid glucorticoid inhibition of vasoactive intestine peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture. Proc. Natl. Acad. Sci. USA 78: 7584, 1981.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  41. Oliva D., Nicosia S., Spada A., Giannattasio G. VIP stimulates ACTH release and adenylate cyclase in human ACTH-secreting pituitary adenomas. Eur. J. Pharmacol. 83: 101, 1982.

    Article  PubMed  CAS  Google Scholar 

  42. Salmon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58: 541, 1974.

    Article  Google Scholar 

  43. Labrie F., Borgeat P., Drouin J., Beaulieu M, Lagace L., Ferland L., Raymond V. Mechanism of action of hypothalamic hormones in the adenohypophysis. Annu. Rev. Physiol. 41: 555, 1979.

    Article  PubMed  CAS  Google Scholar 

  44. Borghi C., Nicosia S., Giachetti A., Said S.I. Adenylate cyclase of rat pituitary gland. Stimulation by Vasoactive Intestinal Polypeptide (VIP). FEBS Lett. 108: 403, 1979.

    Article  PubMed  CAS  Google Scholar 

  45. Robberecht P., Deschodt-Lanckman M., Camus J.-C., De Neef P., Lambert M, Christophe J. VIP activation of rat anterior pituitary adenylate cyclase. FEBS Lett. 103: 229, 1979.

    Article  PubMed  CAS  Google Scholar 

  46. De Camilli P., Zanini A., Giannattasio G., Meldolesi J. Synthesis, intracellular transport, packaging and release of growth hormone and prolactin in normal and tumoral pituitary cells. In: Faglia G., Giovanelli M.A., Me Leod R.M. (Eds.), Pituitary microadenomas. Academic Press, London, 1980, p. 55.

    Google Scholar 

  47. Bataille D., Peillon F., Besson J., Rosselin G. Vasoactive Intestinal Peptide (VIP): recepteurs specifiques et activation de I’adenylate cyclase dans une tumeur hypophysaire humaine a prolactine. C.R. Acad. Sc. Paris 288: 1315, 1979.

    CAS  Google Scholar 

  48. Onali P., Schwartz J.P., Costa E. Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary. Proc. Natl. Acad. Sci. USA 78: 6531, 1981.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  49. De Camilli P., Macconi D., Spada A. Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas. Nature 278: 252, 1979.

    Article  PubMed  Google Scholar 

  50. Maurer R.A. Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP. Nature 294: 94, 1981.

    Article  PubMed  CAS  Google Scholar 

  51. Szabo M., Frohman L.A. Dissociation of prolactin-releasing activity from thyrotropin-releasing hormone in porcine stalk median eminence. Endocrinology 98: 1451, 1976.

    Article  PubMed  CAS  Google Scholar 

  52. Chiocchio S.A., Cannata M.A., Corderofunes J.R., Tramezzani J.H. Involvement of adenohypophyseal dopamine in the regulation of prolactin release during suckling. Endocrinology 105: 544, 1979.

    Article  PubMed  CAS  Google Scholar 

  53. Fine S.A., Frohman L.A. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. J. Clin. Invest. 61: 973, 1978.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nicosia, S., Oliva, D., Giannattasio, G. et al. The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone. J Endocrinol Invest 6, 235–242 (1983). https://doi.org/10.1007/BF03350614

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350614

Key-words

Navigation